Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV): Survival analysis from NAPOLI-1

L. T. Chen, T. M. Macarulla, J. Blanc, B. Mirakhur, F. A. de Jong, B. Belanger, T. Bekaii-Saab, J. Siveke

Research output: Contribution to journalArticle

108 Scopus citations
Original languageEnglish (US)
Pages (from-to)viii250-viii251
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this